Victoria CarrBrendel - Sonova Holding President
| SONVY Stock | USD 68.85 0.01 0.01% |
President
Dr. Victoria E. CarrBrendel, Ph.D. is Group Vice President Cochlear Implants, President of Advanced Bionics and Member of the Management Board of Sonova Holding Ltd. of since April 1, 2019. She joins Sonova from JenaValve Technology Inc., a global and innovative transcatheter heart valve company, where she became CEO in mid2015. She is an accomplished medical device executive with vast experience across several therapeutic areas. She started her career as a scientist in research and development, and took on increasingly larger business roles throughout her career. At JenaValve, she was responsible for bringing the company through new product development, clinical trial completion for CE mark, and optimizing the commercial launch of their next generation valve and system. Prior to her present position, she worked as Franchise General Manager at Boston Scientific, in the Peripheral Interventions division, where she ran global business operations, including the Bayer interventional radiology acquisition. Vicky has a successful track record of growing businesses and improving profitability. Having spent her entire career in healthcare, she has a background as an innovation and growth leader, bringing with her marketing, development, clinical and strategic business experience in the medical device sector. She holds a Ph.D. in microbiology and immunology and she spent 18 years in various management roles. Vicky will join Advanced Bionics on December 3, 2018 and will take over full responsibility as President. since 2019.
| Age | 59 |
| Tenure | 5 years |
| Professional Marks | Ph.D |
| Phone | 41 58 928 33 33 |
| Web | https://www.sonova.com |
Sonova Holding Management Efficiency
The company has return on total asset (ROA) of 0.0879 % which means that it generated a profit of $0.0879 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2878 %, meaning that it generated $0.2878 on every $100 dollars invested by stockholders. Sonova Holding's management efficiency ratios could be used to measure how well Sonova Holding manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | PRESIDENT Age | ||
| Brent Hauser | Cutera Inc | 47 | |
| Hemanth CFA | Venus Concept | 48 | |
| Michael Karavitis | Cutera Inc | 54 | |
| Gregg Sutton | SurModics | 64 | |
| Jonathan Harris | Owlet Inc | 59 | |
Management Performance
| Return On Equity | 0.29 | |||
| Return On Asset | 0.0879 |
Sonova Holding AG Leadership Team
Elected by the shareholders, the Sonova Holding's board of directors comprises two types of representatives: Sonova Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonova. The board's role is to monitor Sonova Holding's management team and ensure that shareholders' interests are well served. Sonova Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonova Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christophe Fond, Group Vice President Retail | ||
| Robert Woolley, Group Board | ||
| Jan Metzdorff, Member of the Management Board | ||
| Ludger Althoff, Vice President - Operations | ||
| Arnd Kaldowski, COO, Member of the Management Board | ||
| Claudio Bartesaghi, Member of the Management Board, Group Vice President Corporate Human Resources, Corporate Communications | ||
| Thomas Bernhardsgrutter, Director Relations | ||
| Martin Grieder, Vice President Phonak, Member of the Management Board | ||
| Birgit Conix, CFO Board | ||
| Victoria CarrBrendel, Group Vice President Cochlear Implants and Presidentident of Advanced Bionics and Member of the Management Board |
Sonova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonova Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.29 | |||
| Return On Asset | 0.0879 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 15.94 B | |||
| Shares Outstanding | 305.8 M | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | 45.95 X | |||
| Price To Book | 7.55 X | |||
| Price To Sales | 4.10 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sonova Pink Sheet Analysis
When running Sonova Holding's price analysis, check to measure Sonova Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonova Holding is operating at the current time. Most of Sonova Holding's value examination focuses on studying past and present price action to predict the probability of Sonova Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonova Holding's price. Additionally, you may evaluate how the addition of Sonova Holding to your portfolios can decrease your overall portfolio volatility.